Barikind 4 Tablet
Marketer
Mankind Pharma Ltd
Salt Composition
Baricitinib (4mg)
Overview Barikind 4 Tablet
For hospitalized adults with COVID-19, Remdesivir therapy is enhanced by the concomitant use of Barikind 4 Tablets. Administration of Barikind 4 Tablets is flexible—with or without food—but consistent daily timing is recommended. Dosage is individualized, considering your health status and other medications. Always follow your physician's instructions; abrupt cessation is discouraged as it may worsen your condition. Commonly reported adverse effects include upper respiratory tract infections, nausea, and viral illnesses; less frequent but potentially serious complications involve gastrointestinal bleeding, blood clots, and cold sores. Seek immediate medical care if serious side effects occur. Pre-treatment blood work may be necessary, and initiation is contraindicated with existing infections. Prior to commencing treatment, inform your physician of any history of tuberculosis, herpes zoster, hepatic or renal impairment, hepatitis B or C, or thromboembolic events. Barikind 4 Tablets increase susceptibility to infection; contact with contagious individuals (e.g., those with influenza, measles, or varicella) should be minimized. This medication is not approved for individuals under 18 years of age or during pregnancy/breastfeeding, unless deemed clinically necessary by your doctor. Regular monitoring by your physician may be required.
Uses of Barikind 4 Tablet
Managing Coronavirus Infection (COVID-19)
Major Benefits of Barikind 4 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Barikind 4 Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Barikind 4 Tablet:
- Upper respiratory tract infection
- Nausea
- Herpes virus infection
- Cold sores
- Viral infection
- Sore throat
How to use Barikind 4 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. The tablet should be swallowed whole; avoid crushing, chewing, or breaking it. Barikind 4 Tablet can be administered with or without food, although consistent timing is recommended.
How Barikind 4 Tablet works:
Barikind 4 Tablets contain a JAK inhibitor that selectively blocks JAK1 and JAK2 enzymes, thereby disrupting the JAK-STAT signaling cascade. This pathway governs crucial cellular processes, including immune responses, cell proliferation, apoptosis, and oncogenesis.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Barikind 4 Tablet and alcohol consumption.
PregnancyCONSULT YOUR DOCTOR
Use of Barikind 4 Tablet is contraindicated in pregnancy due to established risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingCONSULT YOUR DOCTOR
The use of Barikind 4 Tablet while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Barikind 4 Tablet.
KidneyUNSAFE
The use of Barikind 4 Tablet is contraindicated in individuals with kidney impairment; its administration is inadvisable. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
For individuals with liver disease, Barikind 4 Tablet is generally considered safe, and no dosage alteration is typically advised. However, its use in patients exhibiting severe hepatic impairment is not recommended owing to insufficient data. Physician consultation is essential.
What if you forget to take Barikind 4 Tablet :
NA
Facts to Know About Barikind 4 Tablet
| Label | Value |
|---|---|
| Chemical Type | Pyrrolopyrimidine Compound |
| Developing Habits | No. |
| Type of Therapy | Pain Relievers |
| Actions | JAK inhibitors |



